Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jun 1, 2007

BMS Signs Research Services Agreement with Immunicon for Oncology Biomarker Development

  • Immunicon entered into a research services agreement with Bristol-Myers Squibb involving protein and molecular targets associated with circulating tumor cells.

    “Our collaborations span across protein biomarkers, phosphoproteins, and a variety of FISH assays to study gene amplification in a number of different carcinomas. We believe that our development work will advance the understanding of cancer biology as well as accelerate the time to market for promising new drugs,” comments Leon Terstappen, M.D., Ph.D., CSO at Immunicon.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »